Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Journal of Vascular Surgery

• Publication date

  1994-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0741-5214(94)70012-5PMID 8170041
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Connective tissue proteinases and inhibitors in abdominal aortic aneurysms

  1993cited by this paper
• Pathogenesis of acquired aneurysms of the abdominal aorta

  1992cited by this paper
• Characterization of an elastase from aneurysmal aorta which degrades intact aortic elastin

  1992cited by this paper
• Quantification of free tissue‐type plasminogen activator in plasma from patients undergoing coronary thrombolysis

  1992cited by this paper
• Regulation of fibrinolysis by vascular endothelium

  1991cited by this paper
• Connective tissue proteinases and inhibitors in abdominal aortic aneurysms. Involvement of the vasa vasorum in the pathogenesis of aortic aneurysms.

  1991cited by this paper
• Metalloproteinases in degenerative aortic disease.

  1991cited by this paper
• Human 92- and 72-kilodalton type IV collagenases are elastases.

  1991cited by this paper
• The role of inflammation in nonspecific abdominal aortic aneurysm disease

  1991cited by this paper
• Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo.

  1990cited by this paper
• Elastase-induced experimental aneurysms in rats.

  1990cited by this paper
• Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.

  1990cited by this paper
• [Type 1 plasminogen activator inhibitor].

  1990cited by this paper
• Elastase and cathepsin G of human monocytes. Quantification of cellular content, release in response to stimuli, and heterogeneity in elastase-mediated proteolytic activity.

  1989cited by this paper
• Collagen types and matrix protein content in human abdominal aortic aneurysms.

  1989cited by this paper
• SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages.

  1989cited by this paper
• Type 1 plasminogen activator inhibitor.

  1989cited by this paper
• Dependence of fibrinolytic activity on the concentration of free rather than total tissue-type plasminogen activator in plasma after pharmacologic administration.

  1989cited by this paper
• Tissue cooperation in a proteolytic cascade activating human interstitial collagenase.

  1989cited by this paper
• Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications.

  1988cited by this paper
• Histochemistry of aortic elastin in patients with nonspecific abdominal aortic aneurysmal disease.

  1988cited by this paper
• Regulation of the expression of type 1 plasminogen activator inhibitor in Hep G2 cells by epidermal growth factor.

  1988cited by this paper
• Sensitive and specific enzyme-linked immunosorbent assay for urokinase-type plasminogen activator and its application to plasma from patients with breast cancer.

  1988cited by this paper
• Altered aortic protease and antiprotease activity in patients with ruptured abdominal aortic aneurysms.

  1987cited by this paper
• Monocyte procollagenase and tissue inhibitor of metalloproteinases. Identification, characterization, and regulation of secretion.

  1987cited by this paper
• Elastin degradation in abdominal aortic aneurysms.

  1987cited by this paper
• Quantitation of urokinase antigen in plasma and culture media by use of an ELISA.

  1986cited by this paper
• Human recombinant interleukin 1 stimulates collagenase and prostaglandin E2 production by human synovial cells.

  1986cited by this paper
• Human alveolar macrophages produce a fibroblast-like collagenase and collagenase inhibitor.

  1985cited by this paper
• Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene.

  1985cited by this paper
• Degradation of fibrin and elastin by intact human alveolar macrophages in vitro. Characterization of a plasminogen activator and its role in matrix degradation.

  1984cited by this paper
• Identification and primary sequence of an unspliced human urokinase poly(A)+ RNA.

  1984cited by this paper
• "A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity". Addendum.

  1984cited by this paper
• Elastolytic proteinases of the human macrophage.

  1983cited by this paper
• A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity.

  1983cited by this paper
• Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli

  1983cited by this paper
• Improved medium for extraction of plasminogen activator from tissue.

  1982cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• Degradation of connective tissue matrices by macrophages. I. Proteolysis of elastin, glycoproteins, and collagen by proteinases isolated from macrophages

  1980cited by this paper
• Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose.

  1980cited by this paper
• Degradation of connective tissue matrices by macrophages. III. Morphological and biochemical studies on extracellular, pericellular, and intracellular events in matrix proteolysis by macrophages in culture

  1980cited by this paper
• Collagenase activity of the human aorta. A comparison of patients with and without abdominal aortic aneurysms.

  1980cited by this paper
• Participation of monocyte-macrophages and lymphocytes in the production of a factor that stimulates collagenase and prostaglandin release by rheumatoid synovial cells.

  1979cited by this paper
• A study of proteases and protease-inhibitor complexes in biological fluids

  1978cited by this paper
• Rat insulin genes: construction of plasmids containing the coding sequences.

  1977cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• tPA-NMDAR Signaling Blockade Reduces the Incidence of Intracerebral Aneurysms

  2022cites this paper
• Intraluminal thrombus: Innocent bystander or factor in abdominal aortic aneurysm pathogenesis?

  2021cites this paper
• Studies into the Effects of Hypoxia on Matrix Metalloproteinases within the Abdominal Aortic Aneurysm

  2016cites this paper
• Concomitance of atherosclerotic lesions in arteries of the lower extremities and carotid arteries in patients with abdominal aorta aneurysm

  2016cites this paper
• Biomarkers for Abdominal Aortic Aneurysm

  2015cites this paper
• The Role of Endothelial Dysfunction in Aortic Aneurysms.

  2015cites this paper
• Circulating biomarkers for abdominal aortic aneurysm: what did we learn in the last decade?

  2013cites this paper
• Chapter 37 – Pathophysiology, Epidemiology, and Prognosis of Aortic Aneurysms

  2013cites this paper
• Increased PAI-1 in females compared with males is protective for abdominal aortic aneurysm formation in a rodent model.

  2012cites this paper
• Treatment with simvastatin inhibits the formation of abdominal aortic aneurysms in rabbits.

  2012cites this paper
• Natural History and Treatment of Aneurysms

  2011cites this paper
• Downregulation of remodelling enzymatic activity induced by an angiotensin-converting enzyme inhibitor (perindopril) reduces the degeneration of experimental abdominal aortic aneurysms in a rat model.

  2011cites this paper
• Expression and localization of vascular endothelial growth factor in normal abdominal aorta and abdominal aortic aneurysm.

  2010cites this paper
• Expression of annexin II in experimental abdominal aortic aneurysms

  2009cites this paper
• Expression of annexin II in human atherosclerotic abdominal aortic aneurysms.

  2008cites this paper
• Diseases of the Thoracic Aorta

  2008cites this paper
• Elevated tissue plasminogen activator in patients with screening-detected abdominal aortic aneurysm.

  2007cites this paper
• Coagulation and fibrinolysis in the abluminal layer of the thrombus within abdominal aortic aneurysm

  2007cites this paper
• Topology of the fibrinolytic system within the mural thrombus of human abdominal aortic aneurysms

  2007cites this paper
• ATVB In Focus Abdominal Aortic Aneurysms: Pathophysiological Mechanisms and Clinical Implications

  2006cites this paper
• Pharmacological targets in the treatment of abdominal aortic aneurysms

  2006cites this paper
• Abdominal Aortic Aneurysms : Pathophysiological Mechanisms and Clinical Implications Series

  2006cites this paper
• Activators of Plasminogen and the Progression of Small Abdominal Aortic Aneurysms

  2006cites this paper
• Inflammation and cellular immune responses in abdominal aortic aneurysms.

  2006cites this paper
• Influence of Indomethacin in the Rat Aneurysm Model

  2006cites this paper
• Intraluminal Thrombus Enhances Proteolysis in Abdominal Aortic Aneurysms

  2006cites this paper
• An investigation into the cytokine expression profile of the abdominal aortic aneurysm wall.

  2006cites this paper
• chapter 37 – Pathophysiology, Epidemiology, and Prognosis

  2006cites this paper
• Influence of Indornethacin in the Rat

  2006cites this paper
• Hyperplastic Cellular Remodeling of the Media in Ascending Thoracic Aortic Aneurysms

  2005cites this paper
• A review of biological factors implicated in abdominal aortic aneurysm rupture.

  2005cites this paper
• Local cytokine environments drive aneurysm formation in allografted aortas.

  2005cites this paper
• The pathobiology of aortic aneurysms.

  2004cites this paper
• Matrix metalloproteinases: contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms

  2004cites this paper
• Gene Polymorphisms for PAI-1 Are Associated with the Angiographic Extent of Coronary Artery Disease

  2004cites this paper
• Zymographic evaluation of plasminogen activators and plasminogen activator inhibitors.

  2004cites this paper
• Gradient of proteolytic enzymes, their inhibitors and matrix proteins expression in a ruptured abdominal aortic aneurysm

  2004cites this paper
• Gene targeting and gene transfer studies of the plasminogen / plasmin system : implications in thrombosis , hemostasis , neointima formation , and atherosclerosis

  2004cites this paper
• Novel aspects and new roles for the serine protease plasmin

  2004cites this paper
• Relationships between activators and inhibitors of plasminogen, and the progression of small abdominal aortic aneurysms.

  2003cites this paper
• Diseases of the Thoracic Aorta and Great Vessels

  2003cites this paper
• Expression of angiogenesis and angiogenic factors in human aortic vascular disease.

  2002cites this paper
• Matrix Metalloproteinase Expressions in Arteriosclerotic Aneurysmal Disease

  2002cites this paper
• Abdominal aortic aneurysms: basic mechanisms and clinical implications.

  2002cites this paper
• The influence of 4G/5G polymorphism in the plasminogen activator inhibitor-1 gene promoter on the incidence, growth and operative risk of abdominal aortic aneurysm.

  2002cites this paper
• Mechanisms of abdominal aortic aneurysm formation

  2002cites this paper
• Abnormal levels of urokinase plasminogen activator protein and tissue plasminogen activator activity in human aortic aneurysms.

  2001cites this paper
• Plasmin and Matrix Metalloproteinases in Vascular Remodeling

  2001influential citation
• Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.

  2001cites this paper
• Persistence of Atherosclerotic Plaque but Reduced Aneurysm Formation in Mice With Stromelysin-1 (MMP-3) Gene Inactivation

  2001cites this paper
• Genetic Evaluation of Lipoprotein(a) in Intracranial Aneurysm Disease

  2001cites this paper
• Experimental Abdominal Aortic Aneurysms in Mice Lacking Expression of Inducible Nitric Oxide Synthase

  2001cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Enhanced Expression of Matrix Metalloproteinase-9 in Abdominal Aortic Aneurysms

  2001cites this paper
• Elastin-laminin receptor and abdominal aortic aneurysms. New subject to study? A review.

  2001cites this paper
• Hypertriglyceridemic VLDL downregulates tissue plasminogen activator gene transcription through cis-repressive region(s) in the tissue plasminogen activator promoter in cultured human endothelial cells.

  2000cites this paper
• Association of the 4G/5G polymorphism in the promoter region of plasminogen activator inhibitor-1 with abdominal aortic aneurysms.

  2000cites this paper
• New perspectives in abdominal aortic aneurysm management

  2000cites this paper
• Functional importance of connective tissue repair during the development of experimental abdominal aortic aneurysms.

  2000cites this paper
• Matrix metalloproteinases. Their role in degenerative chronic diseases of abdominal aorta.

  1999cites this paper
• Indomethacin inhibits expansion of experimental aortic aneurysms via inhibition of the cox2 isoform of cyclooxygenase.

  1999cites this paper
• Overexpression of tissue-type plasminogen activator in atherosclerotic human coronary arteries.

  1999cites this paper
• Relation of Urokinase-Type Plasminogen Activator Expression to Presence and Severity of Atherosclerotic Lesions in Human Coronary Arteries

  1998influential citation
• Expression of Matrix Metalloproteinases and TIMPs in Human Abdominal Aortic Aneurysms

  1998cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  1998cites this paper
• Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms.

  1998cites this paper
• Prevention of aneurysm development and rupture by local overexpression of plasminogen activator inhibitor-1.

  1998cites this paper
• Patterns of expression of fibrinolytic genes and matrix metalloproteinase-9 in dissecting aortic aneurysms.

  1998cites this paper
• Vascular extracellular matrix remodeling in cerebral aneurysms.

  1998cites this paper
• An activated state of blood coagulation and fibrinolysis in patients with abdominal aortic aneurysm.

  1998cites this paper
• Expression of Fibrinolytic Genes in Tissues from Human Atherosclerotic Aneurysms and from Obese Mice

  1997cites this paper
• Elevated circulating levels of inflammatory cytokines in patients with abdominal aortic aneurysm.

  1997cites this paper
• Elevations of tissue-type plasminogen activator and differential expression of urokinase-type plasminogen activator in diseased aorta.

  1997cites this paper
• Aneurysmen und dilatative Angiopathie

  1997cites this paper
• Prostaglandin E2 synthesis and cyclooxygenase expression in abdominal aortic aneurysms.

  1997cites this paper
• Basic science of abdominal aortic aneurysms: emerging therapeutic strategies for an unresolved clinical problem.

  1996cites this paper
• Pathogenesis of abdominal aortic aneurysms--cellular and biochemical mechanisms.

  1996cites this paper
• Vascular aneurysms: a side-splitting affair.

  1996cites this paper
• Role of Matrix Metalloproteinases in Abdominal Aortic Aneurysms a

  1996cites this paper
• Medical control of abdominal aortic aneurysm expansion rate.

  1996cites this paper
• Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.

  1996cites this paper
• Fibrinolysis and risk of coronary artery disease

  1996cites this paper
• Inflammatory aspects of experimental aneurysms. Effect of methylprednisolone and cyclosporine.

  1996cites this paper
• Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat.

  1996cites this paper
• Extracellular proteolysis and the migrating vascular smooth muscle cell

  1996cites this paper
• Mini-review Vascular aneurysms: a side-splitting affair

  1996cites this paper
• Plasminogen Activators in Abdominal Aortic Aneurysmal Disease

  1996cites this paper
• Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta.

  1996cites this paper
• Gene targeting and gene transfer studies of the plaeminogen/plasmin system: implications in thrombosis, hemostasis, neointima formation, and atherosclerosis

  1995cites this paper
• Production and localization of 92-kilodalton gelatinase in abdominal aortic aneurysms. An elastolytic metalloproteinase expressed by aneurysm-infiltrating macrophages.

  1995cites this paper
• Medial neovascularization in abdominal aortic aneurysms: a histopathologic marker of aneurysmal degeneration with pathophysiologic implications.

  1995cites this paper
• Physiological consequences of over- or under-expression of fibrinolytic system components in transgenic mice.

  1995cites this paper
• Plasminogen activator and plasminogen activator inhibitor expression by normal and aneurysmal human aortic smooth muscle cells in culture.

  1995cites this paper
• Expression of fibrinolytic genes in atherosclerotic abdominal aortic aneurysm wall. A possible mechanism for aneurysm expansion.

  1995cites this paper
• The Control of tPA and PAI-1 Secretion from the Vessel Wall

  1995cites this paper
• Quantification of plasminogen activators and their inhibitors in the aortic vessel wall in relation to the presence and severity of atherosclerotic disease.

  1995cites this paper
• Plasminogen activator system in human coronary atherosclerosis.

  1995cites this paper
• Regulation of baboon arterial smooth muscle cell plasminogen activators by heparin and growth factors.

  1995cites this paper
• Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals.

  1995cites this paper
• Gene Targeting and Gene Transfer Studies of the Biological Role of the Plasminogen/Plasmin System

  1995cites this paper